Industry Research Reports
Home > Reports > Service & Software > Viral Inactivation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Viral Inactivation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Service & Software
Published Date: 2025-02-27
Pages: 112 Pages
Report ld: 4310671
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Viral Inactivation Market Size(US$)
CAGR 2025-2031
10.1%
Market Size,2031
USD 1,177
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 662 million
Market Forecast in 2031(Value)
US$ 1,177 million
CAGR
10.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Viral Inactivation was estimated to be worth US$ 607 million in 2024 and is forecast to a readjusted size of US$ 1177 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Estimates of their viral inactivation market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
This report aims to provide a comprehensive presentation of the global market for Viral Inactivation, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Viral Inactivation by region & country, by Type, and by Application.
The Viral Inactivation market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Inactivation.
MARKET SEGMENTATION
By Company
- Danaher
- Merck
- Parker Hannifin
- Sartorius
- SGS
- Charles River Laboratories International
- Clean Cells
- Rad Source Technologies
- Texcell
- Viral Inactivated Plasma Systems
- Wuxi Pharmatech (Cayman)
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Kits and Reagents
- Services
- Viral Inactivation Systems and Accessories
Segment by Application
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Stem Cell Products
- Tissue and Tissue Products
- Vaccines and Therapeutics
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Viral Inactivation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Viral Inactivation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Viral Inactivation in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Viral Inactivation Product Introduction
1.2 Global Viral Inactivation Market Size Forecast (2020-2031)
1.3 Viral Inactivation Market Trends & Drivers
1.3.1 Viral Inactivation Industry Trends
1.3.2 Viral Inactivation Market Drivers & Opportunity
1.3.3 Viral Inactivation Market Challenges
1.3.4 Viral Inactivation Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Viral Inactivation Players Revenue Ranking (2024)
2.2 Global Viral Inactivation Revenue by Company (2020-2025)
2.3 Key Companies Viral Inactivation Manufacturing Base Distribution and Headquarters
2.4 Key Companies Viral Inactivation Product Offered
2.5 Key Companies Time to Begin Mass Production of Viral Inactivation
2.6 Viral Inactivation Market Competitive Analysis
2.6.1 Viral Inactivation Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Viral Inactivation Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Inactivation as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Kits and Reagents
3.1.2 Services
3.1.3 Viral Inactivation Systems and Accessories
3.2 Global Viral Inactivation Sales Value by Type
3.2.1 Global Viral Inactivation Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Viral Inactivation Sales Value, by Type (2020-2031)
3.2.3 Global Viral Inactivation Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Blood and Blood Products
4.1.2 Cellular and Gene Therapy Products
4.1.3 Stem Cell Products
4.1.4 Tissue and Tissue Products
4.1.5 Vaccines and Therapeutics
4.2 Global Viral Inactivation Sales Value by Application
4.2.1 Global Viral Inactivation Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Viral Inactivation Sales Value, by Application (2020-2031)
4.2.3 Global Viral Inactivation Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Viral Inactivation Sales Value by Region
5.1.1 Global Viral Inactivation Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Viral Inactivation Sales Value by Region (2020-2025)
5.1.3 Global Viral Inactivation Sales Value by Region (2026-2031)
5.1.4 Global Viral Inactivation Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Viral Inactivation Sales Value, 2020-2031
5.2.2 North America Viral Inactivation Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Viral Inactivation Sales Value, 2020-2031
5.3.2 Europe Viral Inactivation Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Viral Inactivation Sales Value, 2020-2031
5.4.2 Asia Pacific Viral Inactivation Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Viral Inactivation Sales Value, 2020-2031
5.5.2 South America Viral Inactivation Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Viral Inactivation Sales Value, 2020-2031
5.6.2 Middle East & Africa Viral Inactivation Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Viral Inactivation Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Viral Inactivation Sales Value, 2020-2031
6.3 United States
6.3.1 United States Viral Inactivation Sales Value, 2020-2031
6.3.2 United States Viral Inactivation Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Viral Inactivation Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Viral Inactivation Sales Value, 2020-2031
6.4.2 Europe Viral Inactivation Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Viral Inactivation Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Viral Inactivation Sales Value, 2020-2031
6.5.2 China Viral Inactivation Sales Value by Type (%), 2024 VS 2031
6.5.3 China Viral Inactivation Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Viral Inactivation Sales Value, 2020-2031
6.6.2 Japan Viral Inactivation Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Viral Inactivation Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Viral Inactivation Sales Value, 2020-2031
6.7.2 South Korea Viral Inactivation Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Viral Inactivation Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Viral Inactivation Sales Value, 2020-2031
6.8.2 Southeast Asia Viral Inactivation Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Viral Inactivation Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Viral Inactivation Sales Value, 2020-2031
6.9.2 India Viral Inactivation Sales Value by Type (%), 2024 VS 2031
6.9.3 India Viral Inactivation Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Danaher
7.1.1 Danaher Profile
7.1.2 Danaher Main Business
7.1.3 Danaher Viral Inactivation Products, Services and Solutions
7.1.4 Danaher Viral Inactivation Revenue (US$ Million) & (2020-2025)
7.1.5 Danaher Recent Developments
7.2 Merck
7.2.1 Merck Profile
7.2.2 Merck Main Business
7.2.3 Merck Viral Inactivation Products, Services and Solutions
7.2.4 Merck Viral Inactivation Revenue (US$ Million) & (2020-2025)
7.2.5 Merck Recent Developments
7.3 Parker Hannifin
7.3.1 Parker Hannifin Profile
7.3.2 Parker Hannifin Main Business
7.3.3 Parker Hannifin Viral Inactivation Products, Services and Solutions
7.3.4 Parker Hannifin Viral Inactivation Revenue (US$ Million) & (2020-2025)
7.3.5 Parker Hannifin Recent Developments
7.4 Sartorius
7.4.1 Sartorius Profile
7.4.2 Sartorius Main Business
7.4.3 Sartorius Viral Inactivation Products, Services and Solutions
7.4.4 Sartorius Viral Inactivation Revenue (US$ Million) & (2020-2025)
7.4.5 Sartorius Recent Developments
7.5 SGS
7.5.1 SGS Profile
7.5.2 SGS Main Business
7.5.3 SGS Viral Inactivation Products, Services and Solutions
7.5.4 SGS Viral Inactivation Revenue (US$ Million) & (2020-2025)
7.5.5 SGS Recent Developments
7.6 Charles River Laboratories International
7.6.1 Charles River Laboratories International Profile
7.6.2 Charles River Laboratories International Main Business
7.6.3 Charles River Laboratories International Viral Inactivation Products, Services and Solutions
7.6.4 Charles River Laboratories International Viral Inactivation Revenue (US$ Million) & (2020-2025)
7.6.5 Charles River Laboratories International Recent Developments
7.7 Clean Cells
7.7.1 Clean Cells Profile
7.7.2 Clean Cells Main Business
7.7.3 Clean Cells Viral Inactivation Products, Services and Solutions
7.7.4 Clean Cells Viral Inactivation Revenue (US$ Million) & (2020-2025)
7.7.5 Clean Cells Recent Developments
7.8 Rad Source Technologies
7.8.1 Rad Source Technologies Profile
7.8.2 Rad Source Technologies Main Business
7.8.3 Rad Source Technologies Viral Inactivation Products, Services and Solutions
7.8.4 Rad Source Technologies Viral Inactivation Revenue (US$ Million) & (2020-2025)
7.8.5 Rad Source Technologies Recent Developments
7.9 Texcell
7.9.1 Texcell Profile
7.9.2 Texcell Main Business
7.9.3 Texcell Viral Inactivation Products, Services and Solutions
7.9.4 Texcell Viral Inactivation Revenue (US$ Million) & (2020-2025)
7.9.5 Texcell Recent Developments
7.10 Viral Inactivated Plasma Systems
7.10.1 Viral Inactivated Plasma Systems Profile
7.10.2 Viral Inactivated Plasma Systems Main Business
7.10.3 Viral Inactivated Plasma Systems Viral Inactivation Products, Services and Solutions
7.10.4 Viral Inactivated Plasma Systems Viral Inactivation Revenue (US$ Million) & (2020-2025)
7.10.5 Viral Inactivated Plasma Systems Recent Developments
7.11 Wuxi Pharmatech (Cayman)
7.11.1 Wuxi Pharmatech (Cayman) Profile
7.11.2 Wuxi Pharmatech (Cayman) Main Business
7.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Products, Services and Solutions
7.11.4 Wuxi Pharmatech (Cayman) Viral Inactivation Revenue (US$ Million) & (2020-2025)
7.11.5 Wuxi Pharmatech (Cayman) Recent Developments
8 Industry Chain Analysis
8.1 Viral Inactivation Industrial Chain
8.2 Viral Inactivation Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Viral Inactivation Sales Model
8.5.2 Sales Channel
8.5.3 Viral Inactivation Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Viral Inactivation Market Trends
Table 2. Viral Inactivation Market Drivers & Opportunity
Table 3. Viral Inactivation Market Challenges
Table 4. Viral Inactivation Market Restraints
Table 5. Global Viral Inactivation Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Viral Inactivation Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Viral Inactivation Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Viral Inactivation Product Type
Table 9. Key Companies Time to Begin Mass Production of Viral Inactivation
Table 10. Global Viral Inactivation Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Inactivation as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Viral Inactivation Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Viral Inactivation Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Viral Inactivation Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Viral Inactivation Sales Market Share in Value by Type (2020-2025)
Table 17. Global Viral Inactivation Sales Market Share in Value by Type (2026-2031)
Table 18. Global Viral Inactivation Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Viral Inactivation Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Viral Inactivation Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Viral Inactivation Sales Market Share in Value by Application (2020-2025)
Table 22. Global Viral Inactivation Sales Market Share in Value by Application (2026-2031)
Table 23. Global Viral Inactivation Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Viral Inactivation Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Viral Inactivation Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Viral Inactivation Sales Value by Region (2020-2025) & (%)
Table 27. Global Viral Inactivation Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Viral Inactivation Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Viral Inactivation Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Viral Inactivation Sales Value, (2026-2031) & (US$ Million)
Table 31. Danaher Basic Information List
Table 32. Danaher Description and Business Overview
Table 33. Danaher Viral Inactivation Products, Services and Solutions
Table 34. Revenue (US$ Million) in Viral Inactivation Business of Danaher (2020-2025)
Table 35. Danaher Recent Developments
Table 36. Merck Basic Information List
Table 37. Merck Description and Business Overview
Table 38. Merck Viral Inactivation Products, Services and Solutions
Table 39. Revenue (US$ Million) in Viral Inactivation Business of Merck (2020-2025)
Table 40. Merck Recent Developments
Table 41. Parker Hannifin Basic Information List
Table 42. Parker Hannifin Description and Business Overview
Table 43. Parker Hannifin Viral Inactivation Products, Services and Solutions
Table 44. Revenue (US$ Million) in Viral Inactivation Business of Parker Hannifin (2020-2025)
Table 45. Parker Hannifin Recent Developments
Table 46. Sartorius Basic Information List
Table 47. Sartorius Description and Business Overview
Table 48. Sartorius Viral Inactivation Products, Services and Solutions
Table 49. Revenue (US$ Million) in Viral Inactivation Business of Sartorius (2020-2025)
Table 50. Sartorius Recent Developments
Table 51. SGS Basic Information List
Table 52. SGS Description and Business Overview
Table 53. SGS Viral Inactivation Products, Services and Solutions
Table 54. Revenue (US$ Million) in Viral Inactivation Business of SGS (2020-2025)
Table 55. SGS Recent Developments
Table 56. Charles River Laboratories International Basic Information List
Table 57. Charles River Laboratories International Description and Business Overview
Table 58. Charles River Laboratories International Viral Inactivation Products, Services and Solutions
Table 59. Revenue (US$ Million) in Viral Inactivation Business of Charles River Laboratories International (2020-2025)
Table 60. Charles River Laboratories International Recent Developments
Table 61. Clean Cells Basic Information List
Table 62. Clean Cells Description and Business Overview
Table 63. Clean Cells Viral Inactivation Products, Services and Solutions
Table 64. Revenue (US$ Million) in Viral Inactivation Business of Clean Cells (2020-2025)
Table 65. Clean Cells Recent Developments
Table 66. Rad Source Technologies Basic Information List
Table 67. Rad Source Technologies Description and Business Overview
Table 68. Rad Source Technologies Viral Inactivation Products, Services and Solutions
Table 69. Revenue (US$ Million) in Viral Inactivation Business of Rad Source Technologies (2020-2025)
Table 70. Rad Source Technologies Recent Developments
Table 71. Texcell Basic Information List
Table 72. Texcell Description and Business Overview
Table 73. Texcell Viral Inactivation Products, Services and Solutions
Table 74. Revenue (US$ Million) in Viral Inactivation Business of Texcell (2020-2025)
Table 75. Texcell Recent Developments
Table 76. Viral Inactivated Plasma Systems Basic Information List
Table 77. Viral Inactivated Plasma Systems Description and Business Overview
Table 78. Viral Inactivated Plasma Systems Viral Inactivation Products, Services and Solutions
Table 79. Revenue (US$ Million) in Viral Inactivation Business of Viral Inactivated Plasma Systems (2020-2025)
Table 80. Viral Inactivated Plasma Systems Recent Developments
Table 81. Wuxi Pharmatech (Cayman) Basic Information List
Table 82. Wuxi Pharmatech (Cayman) Description and Business Overview
Table 83. Wuxi Pharmatech (Cayman) Viral Inactivation Products, Services and Solutions
Table 84. Revenue (US$ Million) in Viral Inactivation Business of Wuxi Pharmatech (Cayman) (2020-2025)
Table 85. Wuxi Pharmatech (Cayman) Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. Viral Inactivation Downstream Customers
Table 89. Viral Inactivation Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Viral Inactivation Product Picture
Figure 2. Global Viral Inactivation Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Viral Inactivation Sales Value (2020-2031) & (US$ Million)
Figure 4. Viral Inactivation Report Years Considered
Figure 5. Global Viral Inactivation Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Viral Inactivation Revenue in 2024
Figure 7. Viral Inactivation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Kits and Reagents Picture
Figure 9. Services Picture
Figure 10. Viral Inactivation Systems and Accessories Picture
Figure 11. Global Viral Inactivation Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 12. Global Viral Inactivation Sales Value Market Share by Type, 2024 & 2031
Figure 13. Product Picture of Blood and Blood Products
Figure 14. Product Picture of Cellular and Gene Therapy Products
Figure 15. Product Picture of Stem Cell Products
Figure 16. Product Picture of Tissue and Tissue Products
Figure 17. Product Picture of Vaccines and Therapeutics
Figure 18. Global Viral Inactivation Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 19. Global Viral Inactivation Sales Value Market Share by Application, 2024 & 2031
Figure 20. North America Viral Inactivation Sales Value (2020-2031) & (US$ Million)
Figure 21. North America Viral Inactivation Sales Value by Country (%), 2024 VS 2031
Figure 22. Europe Viral Inactivation Sales Value, (2020-2031) & (US$ Million)
Figure 23. Europe Viral Inactivation Sales Value by Country (%), 2024 VS 2031
Figure 24. Asia Pacific Viral Inactivation Sales Value, (2020-2031) & (US$ Million)
Figure 25. Asia Pacific Viral Inactivation Sales Value by Region (%), 2024 VS 2031
Figure 26. South America Viral Inactivation Sales Value, (2020-2031) & (US$ Million)
Figure 27. South America Viral Inactivation Sales Value by Country (%), 2024 VS 2031
Figure 28. Middle East & Africa Viral Inactivation Sales Value, (2020-2031) & (US$ Million)
Figure 29. Middle East & Africa Viral Inactivation Sales Value by Country (%), 2024 VS 2031
Figure 30. Key Countries/Regions Viral Inactivation Sales Value (%), (2020-2031)
Figure 31. United States Viral Inactivation Sales Value, (2020-2031) & (US$ Million)
Figure 32. United States Viral Inactivation Sales Value by Type (%), 2024 VS 2031
Figure 33. United States Viral Inactivation Sales Value by Application (%), 2024 VS 2031
Figure 34. Europe Viral Inactivation Sales Value, (2020-2031) & (US$ Million)
Figure 35. Europe Viral Inactivation Sales Value by Type (%), 2024 VS 2031
Figure 36. Europe Viral Inactivation Sales Value by Application (%), 2024 VS 2031
Figure 37. China Viral Inactivation Sales Value, (2020-2031) & (US$ Million)
Figure 38. China Viral Inactivation Sales Value by Type (%), 2024 VS 2031
Figure 39. China Viral Inactivation Sales Value by Application (%), 2024 VS 2031
Figure 40. Japan Viral Inactivation Sales Value, (2020-2031) & (US$ Million)
Figure 41. Japan Viral Inactivation Sales Value by Type (%), 2024 VS 2031
Figure 42. Japan Viral Inactivation Sales Value by Application (%), 2024 VS 2031
Figure 43. South Korea Viral Inactivation Sales Value, (2020-2031) & (US$ Million)
Figure 44. South Korea Viral Inactivation Sales Value by Type (%), 2024 VS 2031
Figure 45. South Korea Viral Inactivation Sales Value by Application (%), 2024 VS 2031
Figure 46. Southeast Asia Viral Inactivation Sales Value, (2020-2031) & (US$ Million)
Figure 47. Southeast Asia Viral Inactivation Sales Value by Type (%), 2024 VS 2031
Figure 48. Southeast Asia Viral Inactivation Sales Value by Application (%), 2024 VS 2031
Figure 49. India Viral Inactivation Sales Value, (2020-2031) & (US$ Million)
Figure 50. India Viral Inactivation Sales Value by Type (%), 2024 VS 2031
Figure 51. India Viral Inactivation Sales Value by Application (%), 2024 VS 2031
Figure 52. Viral Inactivation Industrial Chain
Figure 53. Viral Inactivation Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 10.1% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Viral Inactivation in 2025?
What is the annual compound growth rate of the global Viral Inactivation market size from 2025 to 2031?
What was the global market size of Viral Inactivation in 2031?
Which companies rank high in the global Viral Inactivation market?
Related Reports
Viral Inactivation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Viral Inactivation was estimated to be worth US$ 662 million in 2025 and is projected to reach US$ 1283 million, growing at a CAGR of 10.1% from 2026 to 2032.
Published Date: 2026-07-15
Pages: 120
USD 3950.00
(Single User License)
Global Viral Inactivation Market Research Report 2026
The global Viral Inactivation market was valued at US$ 662 million in 2025 and is anticipated to reach US$ 1283 million by 2032, at a CAGR of 10.1% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 117
USD 2900.00
(Single User License)
Global Viral Inactivation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Viral Inactivation market size was US$ 607 million in 2024 and is forecast to a readjusted size of US$ 1177 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 91
USD 4250.00
(Single User License)
Global Viral Inactivation Market Research Report 2025
The global market for Viral Inactivation was valued at US$ 607 million in the year 2024 and is projected to reach a revised size of US$ 1177 million by 2031, growing at a CAGR of 10.1% during the forecast period.
Published Date: 2025-02-27
Pages: 83
USD 2900.00
(Single User License)
Global Viral Inactivation Market Insights, Forecast to 2030
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Published Date: 2024-04-25
Pages: 106
USD 4900.00
(Single User License)
Global Viral Inactivation Market Research Report 2024
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Published Date: 2024-01-11
Pages: 84
USD 2900.00
(Single User License)
Viral Inactivation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Viral Inactivation was estimated to be worth US$ 662 million in 2025 and is projected to reach US$ 1283 million, growing at a CAGR of 10.1% from 2026 to 2032.
Published: 2026-07-15
Pages: 120
USD 3950.00 (Single User License)Global Viral Inactivation Market Research Report 2026
The global Viral Inactivation market was valued at US$ 662 million in 2025 and is anticipated to reach US$ 1283 million by 2032, at a CAGR of 10.1% from 2026 to 2032.
Published: 2026-04-28
Pages: 117
USD 2900.00 (Single User License)Global Viral Inactivation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Viral Inactivation market size was US$ 607 million in 2024 and is forecast to a readjusted size of US$ 1177 million by 2031 with a CAGR of 10.1% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 91
USD 4250.00 (Single User License)Global Viral Inactivation Market Research Report 2025
The global market for Viral Inactivation was valued at US$ 607 million in the year 2024 and is projected to reach a revised size of US$ 1177 million by 2031, growing at a CAGR of 10.1% during the forecast period.
Published: 2025-02-27
Pages: 83
USD 2900.00 (Single User License)Global Viral Inactivation Market Insights, Forecast to 2030
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Published: 2024-04-25
Pages: 106
USD 4900.00 (Single User License)Global Viral Inactivation Market Research Report 2024
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.
Published: 2024-01-11
Pages: 84
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now